UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19

San Diego Biotechnology Network
San Diego Biotechnology Network
UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19
Loading
/

Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.

Click to view original post